X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18701) 18701
Newspaper Article (4104) 4104
Publication (2684) 2684
Newsletter (361) 361
Book Review (283) 283
Trade Publication Article (260) 260
Book Chapter (224) 224
Magazine Article (174) 174
Book / eBook (83) 83
Conference Proceeding (67) 67
Web Resource (54) 54
Government Document (24) 24
Dissertation (21) 21
Report (7) 7
Reference (3) 3
Data Set (2) 2
Paper (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11221) 11221
immunotherapy (9545) 9545
immune system (8806) 8806
cancer (8162) 8162
humans (7623) 7623
oncology (6851) 6851
immunology (6284) 6284
tumors (5503) 5503
animals (4912) 4912
lymphocytes (4334) 4334
immune response (3973) 3973
cancer therapies (3838) 3838
melanoma (3671) 3671
immune checkpoint (3158) 3158
research (3158) 3158
t cells (3050) 3050
patients (3011) 3011
antigens (2903) 2903
metastasis (2868) 2868
chemotherapy (2845) 2845
medical research (2660) 2660
apoptosis (2644) 2644
care and treatment (2622) 2622
mice (2602) 2602
lymphocytes t (2586) 2586
clinical trials (2550) 2550
proteins (2343) 2343
female (2260) 2260
dendritic cells (2225) 2225
expression (2057) 2057
gene expression (2049) 2049
article (2030) 2030
health aspects (2025) 2025
cell biology (1975) 1975
analysis (1911) 1911
lung cancer (1878) 1878
cytokines (1816) 1816
review (1793) 1793
male (1774) 1774
inflammation (1754) 1754
cytotoxicity (1645) 1645
medicine (1645) 1645
t-cells (1603) 1603
mutation (1585) 1585
nivolumab (1580) 1580
genetic aspects (1456) 1456
studies (1422) 1422
multidisciplinary sciences (1390) 1390
activation (1345) 1345
immunity (1343) 1343
research article (1342) 1342
therapy (1317) 1317
pharmaceutical industry (1312) 1312
regulatory t-cells (1312) 1312
signal transduction (1304) 1304
metastases (1297) 1297
t cell receptors (1296) 1296
survival (1291) 1291
biomarkers (1285) 1285
ligands (1278) 1278
vaccines (1272) 1272
pd-1 (1240) 1240
ipilimumab (1224) 1224
neoplasms - immunology (1211) 1211
medicine, research & experimental (1179) 1179
development and progression (1174) 1174
medical prognosis (1174) 1174
kinases (1163) 1163
middle aged (1117) 1117
biochemistry & molecular biology (1109) 1109
cell death (1109) 1109
drug therapy (1104) 1104
immune checkpoint inhibitors (1104) 1104
immunotherapy - methods (1095) 1095
tumor microenvironment (1090) 1090
immunoglobulins (1064) 1064
biology (1060) 1060
science (1057) 1057
physiological aspects (1056) 1056
pd-1 protein (1050) 1050
breast cancer (1042) 1042
pd-l1 (1039) 1039
pembrolizumab (1036) 1036
prognosis (999) 999
medicine & public health (994) 994
antibodies (989) 989
aged (956) 956
pd-l1 protein (934) 934
deoxyribonucleic acid--dna (932) 932
hematology (927) 927
t-lymphocytes - immunology (917) 917
cells (899) 899
adult (893) 893
macrophages (893) 893
lymphomas (876) 876
in-vivo (874) 874
cd8 antigen (873) 873
disease (873) 873
autoimmunity (859) 859
open-label (856) 856
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
UofT at Mississauga - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
UofT at Scarborough - Stacks (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Trinity College (John W Graham) - Stacks (4) 4
Humber River Regional Hospital - Finch Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Online Resources - Online (2) 2
Women's College Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Oversize (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Reserve desk (1) 1
Knox College (Caven) - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
St. Michael's College (John M. Kelly) - Missing (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Circulation Desk (1) 1
Victoria University E.J. Pratt - Circulation Desk (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23502) 23502
German (160) 160
French (82) 82
Chinese (46) 46
Japanese (39) 39
Korean (16) 16
Spanish (15) 15
Russian (9) 9
Czech (5) 5
Polish (5) 5
Turkish (3) 3
Portuguese (2) 2
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1749 - 1755
Journal Article
Nature, ISSN 0028-0836, 2016, Volume 539, Issue 7629, pp. 443 - 447
Journal Article
Journal Article
Science, ISSN 0036-8075, 10/2018, Volume 362, Issue 6411, pp. 197 - 197
Programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1) checkpoint blockade immunotherapy elicits durable antitumor effects in... 
CELL LUNG-CANCER | MISMATCH-REPAIR DEFICIENCY | MUTATIONAL PROCESSES | METASTATIC MELANOMA | CTLA-4 BLOCKADE | MULTIDISCIPLINARY SCIENCES | COPY NUMBER | PROGRAMMED DEATH LIGAND-1 | SEQUENCING DATA | CLINICAL-RESPONSE | SOMATIC MUTATIONS | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Transcriptome | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Genetic Markers | Cell Cycle Checkpoints | Neoplasms - therapy | Neoplasms - genetics | Antineoplastic Agents, Immunological - therapeutic use | Immunotherapy | Inflammation - genetics | T-Lymphocytes - immunology | Tumor Burden - genetics | Biomarkers, Tumor - genetics | Mutation | Molecular Targeted Therapy - methods | Monoclonal antibodies | Genetic aspects | T cells | Biological markers | Gene expression | Cancer | Tumors | Apoptosis | Cell receptors | Physiological aspects | Diagnosis | Identification and classification | Methods | PD-1 protein | Clinical trials | Genomes | Biology | Lymphocytes T | Microsatellite instability | Data bases | Subgroups | Anticancer properties | Proteins | Cell activation | Pembrolizumab | Databases | Antigenicity | Lymphocytes | Deoxyribonucleic acid--DNA | Medical research | Stability | Microsatellites | Mortality | Melanoma | Data processing | Inflammation | Patients | Immune checkpoint | Cell death | Correlation analysis | PD-L1 protein | Biomarkers | Ligands | Antitumor activity | Cutoffs | Solid tumors
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 2015, Volume 212, Issue 2, pp. 139 - 148
Journal Article
Nature Neuroscience, ISSN 1097-6256, 06/2018, Volume 21, Issue 6, pp. 779 - 786
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article